SCHEMBL13508983

SCHEMBL13508983

CC1(C)c2cc(N(C3=CC=CCC3)c3ccc(-c4cccc5ccccc45)cc3)ccc2-c2c1c1c(c3ccccc23)-c2ccc(N(c3ccccc3)c3ccc(-c4cccc5ccccc45)cc3)cc2C1(C)C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.32
▸ PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13509038 0.92 — —
SCHEMBL13508975 0.89 — —
SCHEMBL13511428 0.89 — —
SCHEMBL13508979 0.88 — —
SCHEMBL13509041 0.87 — —
SCHEMBL13507374 0.87 PPARG (0.37) PPARGPPARA
SCHEMBL13623494 0.85 — —
SCHEMBL13508993 0.84 — —
SCHEMBL13623422 0.84 — —
SCHEMBL13511456 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
EP-2145936-A2 Fluorene and pyrene derivatives and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 PPARG 3235/4885PPARA 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback